Diabetes mellitus is one of the prime risk factors for cardiovascular complications and is
linked with high morbidity and mortality. Diabetic cardiomyopathy (DCM) often manifests as …

Due to their different biological functions, extracellular vesicles (EVs) have great potential
from a therapeutic point of view. They are released by all cell types, carrying and delivering …

Rationale: After myocardial ischemic injury, improper phagocytic clearance of dying cardiac
cells and the ensuing lack of inflammation resolution results in adverse cardiac remodeling …

The inclusion of microRNAs (miRNAs) in extracellular microvesicles/exosomes (named
cardiosomes when deriving from cardiomyocytes) allows their active transportation and …

Cardiovascular diseases (CVDs) are the leading cause of human death worldwide.
Exosomes act as endogenous biological vectors; they possess advantages of low …

Several anticancer agents have been associated with cardiac toxic effects. The currently
proposed mechanisms to explain cardiotoxicity differ among anticancer agents, but in fact …

Although tissue-type plasminogen activator was approved by the FDA for early reperfusion
of occluded vessels, there is a need for an effective neuroprotective drug for stroke patients …

Monitoring the health conditions of the environment and humans is essential for ensuring
human well-being, promoting global health, and achieving sustainability. Innovative …

Background: Endothelial cells (ECs) play a critical role in the maintenance of vascular
homeostasis and in heart function. It was shown that activated fibroblast-derived exosomes …

Recanalization therapy can significantly improve the prognosis of patients with acute
myocardial infarction (AMI). However, infarction or reperfusion-induced cardiomyocyte …